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Herbal and alternative medicine: the impact on anesthesia
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The use of herbal and alternative therapies is increasing all over the developed as well as the developing world. As pharmacological 
data on drug interactions involving herbal therapies becomes available, it is important to be familiar with the challenges that 
concomitant use of these medications may present within the peri-operative period. This review aims to shed light on the more 
commonly used herbal drugs, and to discuss drug interactions and complications that may be expected in their use.
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The use of herbal therapies is fast becoming widespread in both 
developed as well as developing countries.1 These “natural” 
therapies are considered beneficial, but more often than not 
their adverse effects and potential interaction with other drugs 
are not appreciated. Surveys in many developed countries have 
shown that the incidence of herbal medicine use ranges from 
12% of the population in Australia2 to 37% in the USA.3 In South 
Africa it is estimated that as much as 27% of the population use 
herbal preparations as well as prescribed antihypertensive 
therapy to control their blood pressure.4 It is thought that as 
much as one fifth of all patients on prescription medication also 
use herbal remedies, high dose dietary supplements, or both.5 
These figures may be as high as 80% or even higher when 
patients taking traditional herbal medication are included.6–8
A distinction needs to be made between herbal, alternative and 
traditional medicines since the setting is South Africa.
Herbal therapies are defined as plant-derived products that are 
indicated for medicinal or health purposes.9 Herbal therapies 
have been part of human existence since the beginning of time.10 
They span the spectrum from home-brewed teas prepared from 
collected leaves and herbs to products with official approved 
status granted by drug-regulating authorities.
More than 122 distinct plant derived chemical entities with phar-
macological action are known. About 25% of drugs listed in the 
pharmacopoeias of developed countries were isolated from 
plant origin, while another 25% are modifications of molecules 
first found in plants.
A recent survey suggests that as much as 51% of patients use 
herbal medication in the two weeks preceding surgery.11 Of the 
drugs reported, 27% altered clotting, 30% had direct influence 
on cardiac rhythm, rate, blood pressure or serum electrolytes, 
and 20% would increase sedation.
The use of herbal medicines becomes problematic in the peri-
operative setting for a number of reasons:
Disclosure of use to health care practitioner
•  Herbal medicines are perceived as “natural” and therefore 
safe, and more than 70% of patients do not voluntarily 
disclose the use of these drugs to their physicians.12 
Inadequate knowledge of this nature may prove detrimental 
to peri-operative outcome.
•  Physicians may not be familiar with the mechanism of action 
of a specific herb, and may well underestimate the clinical 
effect of the drug.
The influence on pharmacokinetics and –dynamics
•  The degree of alteration in pharmacodynamics and –kinetics 
of concomitantly administered drugs are often unknown, 
making prediction of clinical and side effects impossible. 
Induction and inhibition of both hepatic and intestinal drug 
metabolising enzymes have been suggested in numerous 
studies.13–15 Oral administration of herbs may alter gastric pH 
and motility and accelerate or impair drug delivery to the 
duodenum. Enterocytes are the first barrier that has to be 
crossed for absorption. These cells express high levels of 
CYP3A4 and P-glycoprotein, and the interplay of these are 
needed to determine bioavailability of many drugs. 
Modulation of these factors will determine enhanced or 
reduced bioavailability of co-administered substances.16
•  Of concern to the anaesthetist is the effects these 
medications may have on hepatic metabolism. St John’s 
wort is known to induce the CYP3A4 enzyme system, 
accelerating the metabolism of certain drugs such as 
amitriptyline.17 Other herbal drugs compete for the same 
cytochrome pathway as commonly used anaesthetic agents 
(e.g. echinacea competes with lignocaine for clearance via 
the CYP3A4 system). This may slow down clearance of the 
anaesthetic drug, predisposing the patient to toxic effects 
because of elevated plasma concentrations.
•  Drug interactions between herbal medicines and 
conventional drugs are often not appreciated. Examples 
include St John’s wort and monoamine oxidase inhibitor 
interaction precipitating serotonin syndrome, or the additive 
effect on platelets that garlic and the nonsteroidal anti-
inflammatory drugs have. This is dangerous especially when 
the conventional drug has a narrow therapeutic index (e.g. 
ginseng and warfarin), and relatively small alterations in 
concentration may have profound clinical consequences.18
•  The nett result of interaction may not be predictable 
because interaction may take the form of synergism, 
antagonism, inhibition or even acceleration of metabolism 
of either product. This will lead to pharmacological chaos.19
The risk of systemic toxicity
•  Another sinister complication refers to the ability of a herbal 
drug to enhance the organ toxicity of a concomitantly 
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administered drug. A herb such as echinacea increases the 
hepatotoxicity of drugs such as methotrexate and anabolic 
steroids,20 while halothane will elicit severe dysrhythmias 
when the patient has been using ephedra.21 Contaminants 
found in samples of herbal medication of questionable origin 
may include herbicides, pesticides, radio-isotopes, heavy 
metals and plant derived toxins, all adding to a confusing 
clinical picture when the patient become ill because of use of 
these drugs.22
Multiple adverse effects
•  Adverse events may include increased bleeding, 
cardiovascular complications, prolonged sedation, 
suppression of the central nervous system, and liver or renal 
dysfunction with derangement of drug metabolism and 
elimination.23
•  Adverse effects presenting peri-operatively due to the use of 
herbal medications may not be considered until late in the 
event process. And even when herbal therapies are 
considered in the aetiology of an adverse event, the response 
to standard emergency therapy (cardiovascular support 
drugs or haemostatic agents) may not be as expected.24
•  Many herbal substances may have multiple actions on one 
physiological system – for example, decreased activation of 
clotting by inhibition of von Willebrand factor, and decreased 
platelet aggregation due to glycoprotein receptor 
interference – or, conversely, act on more than one system 
simultaneously, such as effects on both the cardiac 
contractility and haemostasis.
Manufacturing standards and regulatory challenges
•  Because of poor regulation of herbal medicine manufacture, 
true content of different preparations vary greatly between 
different manufacturers.25,26 Therefore estimation of total 
daily dose consumed is often very difficult to calculate.
•  A single herb usually contains a number of bioactive 
components, each of which may contribute in varying 
degrees to the observed pharmacological effect and 
interactions. This, in turn, leads to difficulties in predicting 
and explaining possible mechanisms for herb–drug 
interactions.27
•  Most clinical trials on the efficacy of herbal medication are of 
limited value because of poor study design, small sample size 
and poor quality control.28
•  Legislation prohibits manufacturers of herbal medication 
claiming clinical indications for their products. However, they 
are not prohibited from stating physiological effects for 
herbal drugs.29 Unfortunately, this leads to biased reporting 
where positive effects are overemphasised, while side effects 
are underreported and sometimes not even mentioned, 
perpetuating the notion that these drugs are safe, and their 
use has no negative consequences.
The systemic effects of herbal medication
An overview of clinical effects that commonly used herbal 
preparations have on different physiological systems is presented 
in Table 1.
Many plants are used in blood-related therapies, including as 
blood tonics, to prevent excessive bleeding and as wound 
dressings. The safety and efficacy of these therapies are not 
always scientifically defined, and as such may be associated with 
increased peri-operative blood loss.30 The key is to understand 
whether the preparations have a direct effect on the coagulation 
system, or if disruption is due to drug interaction.
The main direct effect centres on decreased platelet activation 
and aggregation. Mechanisms to explain disaggregation include:
•  Microtubule stabilization31
•  Increased membrane fluidity
•  Reduced tyrosine phosphorylation limiting calcium 
mobilization, arachidonic acid liberation32
•  Decreased / inhibited activation of tissue factor,33 thrombin,34 
plasminogen activator phospholipases, thromboxane A2,
21 
Co-enzyme A and HMG CoA reductase35
•  Potentiation of heparin co-factor II25
•  Increased fibrinolysis36
Increased aggregation or coagulation may be explained through:
•  Increased network protein synthesis and
•  Increased erythrocyte aggregation37
•  Activation of several clotting factors or platelets due to 
glycoconjugates38
Recent literature reviews have attributed adverse coagulation 
effects due to drug–herb interaction in a number of specific 
herbal remedies,41,42 The interaction of these preparations with 
warfarin especially seems to be of significance because of the 
narrow therapeutic index of warfarin. Of specific concern to the 
anaesthetist is the interaction between aloe vera and 
Sevoflurane.43,44
Herbal drugs and the heart
Although epidemiological data support the cardiovascular 
benefits afforded by antioxidants and flavonoids45 present in 
many herbal preparations, clinical trials with purified, single 
compound material have yet to show any benefit46 In fact, 
botanical preparations are many times more likely to induce 
adverse cardiovascular effects including arrhythmias, 
hypertension47 and sympathomimetic effects.48 Reports of 
interference with coagulation, platelet activity and drug 
metabolism (especially where drugs with narrow therapeutic 
windows are used) exist almost exclusively as case reports, and it 
is well known that adverse events of this nature is vastly 
underreported.49 Further effects include direct inhibition of 
contractility, interference with conduction (prolonged QT 
interval), additive effects to cardiac drugs used (especially cardiac 
glycosides) and vasoconstriction or –dilatation.50 All of these may 
cause severe intra-operative complications.
Central nervous system effects of herbal preparations
Many herbal preparations are indicated for their sedating and 
anti-depressive effects.51,52 Since their effects are mediated by 
GABA receptor activation or by serotonin re-uptake inhibition 
(amongst other mechanisms), there is great potential for 
interaction with anaesthetic agents.53 Apart from prolonged 
sedation or the risk of serotonin syndrome, some of these drugs 
may also precipitate seizures54 (due to direct inhibition of anti-
convulsive therapy, accelerated anti-convulsive metabolism, or 
additive excitatory effects with mood stabilizers like trazondone, 
buspirone and fluoxetine). L-Dopa efficacy may be compromised, 
resulting in worsening symptoms of Parkinsonism.55
Hepatic effects of herbal medicines
As many as 60 herbal preparations are known to cause 
derangement of hepatic function.56 This does not include hepatic 
damage attributed to contaminants, impurities, misidentified 
herbs and solvents used in extraction of the active ingredients. 
Herbal therapies may alter drug metabolism by the influence they 
exert on the glucuronidation process, the cytochrome p450 (CYP) 
and other hepatic enzyme systems. CYP inhibition will decrease 
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Table 1: Commonly used herbal drugs with indications, active ingredients and drug interactions21,39,40
Name Indications Active constituents Drug interactions
Aloe vera 
(Aloe vera) 




Inhibits arachidonic acid 
synthesis
Additive to sevoflurane effect on platelets 
 - inhibition of GPIIb/IIIa receptors on platelet 
 - inhibition of GPIa interaction with intercanalicular system 
 - inhibition of von Willebrand – platelet – fibrinogen interaction 









Central nervous system depressants (e.g. opioids,  
benzodiazepines) – increased sedation 
Warfarin, aspirin and NSAIDs – increased risk of bleeding from 
presence of coumarin in chamomile
Echinacea  
(Echinacea. angustifolia,  
E. purpurea, and E. pallida)
Oral – prevent and treat common cold 
and upper respiratory tract infections, 
immunostimulant  
Topical – wound healing, burns, 






Immunosuppressants (e.g. cyclosporine, prednisone,  
azathioprine) – decreased immunosuppressant effects due to 
possible immunostimulation  
Hepatotoxic agents (e.g. acetaminophen, methotrexate, 
amiodarone) – additive hepatotoxicity resulting from  
glutathione depletion 
Inhibition of CYP3A4 and CYP1A2  
increasing levels of drugs metabolized by these enzymes
Evening primrose oil 
(Oenothera biennis)








Gamma-linolenic acid  




Anticonvulsants – risk of seizure 
Anticoagulants and antiplatelet agents – increased risk of 
bleeding 
Anaesthetics– risk of seizure 
Phenothiazines – report of seizures with concomitant use
Feverfew  
(Tanacetum parthenium)
Oral – prevent migraine used for fever, 
arthritis, tinnitus and vertigo 
Topical – toothache and insect bites
Parthenolide – a 
sesquiterpene lactone
Anticoagulants, antiplatelet agents, and NSAIDs – inhibition 





Coronary heart disease 
Bacterial and fungal infections 
Prevention of atherosclerosis
Powdered extract - 1.3% alliin 
Fresh garlic contains 1% alliin, 
allicin, and other organosul-
fur constituents
Protease inhibitors – decreased levels - treatment failure, risk 
of viral resistance 
Non-nucleoside reverse transcriptase inhibitors (NNRTI) – 
decrease serum levels - treatment failure, risk of viral resistance 
Cyclosporine – decrease levels, risk of transplant rejection 
Anticoagulants and antiplatelet agents – increased risk of 
bleeding 
Insulin and antihyperglycemics – enhanced hypoglycaemic 
action 









Antacids, H2 antagonists, proton pump inhibitors – ginger 
increases stomach acid while these medications suppress it 
Anticoagulants, antiplatelet medications, NSAIDs – increased 
risk of bleeding 
Sedatives, barbiturates, benzodiazepines, alcohol – en-
hanced effect 
Blood pressure medications – ginger alters blood pressure 
and interferes with therapy 
Cardiac glycosides – inotropic effect; can alter contractility  
Diabetes medications – additive hypoglycaemic effect
Ginkgo  
(Ginkgo biloba)
Oral – memory loss, Alzheimer’s 
disease, circulatory disorders, 
intermittent claudication and tinnitus 
Topical – frostbite and wound 
dressings
Terpene lactones, 





Primary terpenoids are  
ginkgolides A, B, C, M, and J 
Thiazide diuretics – increased blood pressure 
Anticoagulants, antiplatelet agents, NSAIDS – increased risk 
of bleeding 
Buspirone and fluoxetine – possibility of hypomania 
Trazodone – associated with coma 
Insulin – altered insulin secretion, leading to altered blood 
glucose levels 
Anticonvulsants – decreased efficacy 
Mild inhibitor of CYP3A
Ginseng  
(Panax quinquefolius)
Enhanced stamina, concentration, 




Acute respiratory illness 
Diabetes 
Impotence
Ginsenosides – Rb-1 
Panaxosides
Digoxin – increased effects 
Anticoagulants – decreased efficacy 
Monoamine oxidase inhibito – insomnia, headache, tremor, 
agitation, and worsening of depression 
Diabetes medications – increased risk of hypoglycaemia 
Opioids – decreased analgesic effect 
Oestrogen – additive estrogenic effect
Kava  
(Piper methysticum)
Oral – anxiety, insomnia, restlessness, 
muscle pain, headaches 
Topical – wound healing
Kava-lactones and -pyrones, 
Kawain, dihydrokawain,  
Methysticin, dihydrome-
thysticin, Vangonin
Benzodiazepines – increased lethargy and disorientation 
Levodopa – decreased effectiveness 
CNS depressants, alcohol – additive drowsiness, and depres-
sion of motor reflexes 
(Continued)
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preparations is still incomplete. However, there is a growing body 
of evidence regarding drug interactions and side-effects 
concerning these drugs. Specific enquiry during history taking 
may alert and prepare the peri-operative physician for the most 
likely adverse events. Where unexpected complications occur, 
one must have a high index of suspicion that the patient omitted 
to reveal the usage of herbal medication. No guidelines from 
scientific societies have been published as yet, but most 
authorities agree that all herbal supplements and drugs be 
stopped at least 2 weeks prior to surgery.68
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(Potent inhibitor of 11-β 
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and kessyl glycol
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Inhibition of CYP3A4
Table 1: (Continued)
Notes: CNS: central nervous system, NSAID: nonsteroidal anti-inflammatory drug
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OSSA also conducts several medical training programs 
throughout the year including programs in American 
Heart Associaon (AHA) Basic Life Support (BLS) and 
Pediatric Advanced Life Support (PALS). OSSA 
educa onal programs have benefi ed more than 400 
health care professionals across South Africa.
For more informa on and how YOU can get involved, 
sign up to volunteer with Opera on Smile.
Web: www.opera onsmile.org.za 




Opera on Smile is a non-profit, volunteer medical 
services organiza on providing free reconstruc ve 
surgery in over 60 countries around the world, 
including 13 in Africa.  Our mission principle is: No 
child, in any community, should have to live with the 
pain and isola on caused by a correctable facial 
deformity.
About us:
Opera on Smile South Africa (OSSA) was registered as 
the regional hub for Central and Southern Africa in 
2006. Our inaugural medical mission, which ini ated 
the long term commitment from Opera on Smile to 
South Africa, was conducted in September 2006 in 
Empangeni, KwaZulu Natal.
Since 1982, Opera on Smile, through the help of 
dedicated medical volunteers has provided 220,000 
free surgical procedures for children and adults. Our 
work creates a las ng global impact. 
